These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 30288116)

  • 1. Metabolic syndrome and the risk of cholangiocarcinoma: a hospital-based case-control study in China.
    Xiong J; Lu X; Xu W; Bai Y; Huang H; Bian J; Zhang L; Long J; Xu Y; Wang Z; Zhao H
    Cancer Manag Res; 2018; 10():3849-3855. PubMed ID: 30288116
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proton pump inhibitors and odds of cholangiocarcinoma: A retrospective case-control study.
    Xiong J; Wang Y; Xu W; Liu Z; Wang H; Zhang Z; Han Y; Yin C; Cao S; Yang Z; Su T; Wei J; Chen G; Jin L
    Liver Int; 2020 Nov; 40(11):2848-2857. PubMed ID: 32910500
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk factors for intrahepatic and extrahepatic cholangiocarcinoma: a case-control study in China.
    Tao LY; He XD; Qu Q; Cai L; Liu W; Zhou L; Zhang SM
    Liver Int; 2010 Feb; 30(2):215-21. PubMed ID: 19840244
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The metabolic syndrome and risk factors for biliary tract cancer: a case-control study in China.
    Wu Q; He XD; Yu L; Liu W; Tao LY
    Asian Pac J Cancer Prev; 2012; 13(5):1963-9. PubMed ID: 22901155
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk factors for intrahepatic and extrahepatic cholangiocarcinoma: a hospital-based case-control study.
    Shaib YH; El-Serag HB; Nooka AK; Thomas M; Brown TD; Patt YZ; Hassan MM
    Am J Gastroenterol; 2007 May; 102(5):1016-21. PubMed ID: 17324130
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatitis C virus infection and the risk of intrahepatic cholangiocarcinoma and extrahepatic cholangiocarcinoma: evidence from a systematic review and meta-analysis of 16 case-control studies.
    Li H; Hu B; Zhou ZQ; Guan J; Zhang ZY; Zhou GW
    World J Surg Oncol; 2015 Apr; 13():161. PubMed ID: 25903488
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk factors for intrahepatic and extrahepatic cholangiocarcinoma in the United States: a population-based case-control study.
    Welzel TM; Graubard BI; El-Serag HB; Shaib YH; Hsing AW; Davila JA; McGlynn KA
    Clin Gastroenterol Hepatol; 2007 Oct; 5(10):1221-8. PubMed ID: 17689296
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Viral hepatitis B and C infections increase the risks of intrahepatic and extrahepatic cholangiocarcinoma: Evidence from a systematic review and meta-analysis.
    Tan JH; Zhou WY; Zhou L; Cao RC; Zhang GW
    Turk J Gastroenterol; 2020 Mar; 31(3):246-256. PubMed ID: 32343237
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk factors for intrahepatic and extrahepatic cholangiocarcinoma in the United States: A population-based study in SEER-Medicare.
    Petrick JL; Yang B; Altekruse SF; Van Dyke AL; Koshiol J; Graubard BI; McGlynn KA
    PLoS One; 2017; 12(10):e0186643. PubMed ID: 29049401
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alcoholic liver disease and risk of cholangiocarcinoma: a systematic review and meta-analysis.
    Xiong J; Yin Z; Xu W; Shen Z; Li Y; Lu X
    Onco Targets Ther; 2018; 11():8211-8219. PubMed ID: 30538490
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interactive role of diabetes mellitus and female sex in the risk of cholangiocarcinoma: A population-based nested case-control study.
    Huang YJ; Wu AT; Chiou HY; Chuang MT; Meng TC; Chien LN; Yen Y
    Oncotarget; 2017 Jan; 8(4):6642-6651. PubMed ID: 28036262
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Global trends in mortality from intrahepatic and extrahepatic cholangiocarcinoma.
    Bertuccio P; Malvezzi M; Carioli G; Hashim D; Boffetta P; El-Serag HB; La Vecchia C; Negri E
    J Hepatol; 2019 Jul; 71(1):104-114. PubMed ID: 30910538
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sex-specific and race/ethnicity-specific disparities in cholangiocarcinoma incidence and prevalence in the USA: An updated analysis of the 2000-2011 Surveillance, Epidemiology and End Results registry.
    Mosadeghi S; Liu B; Bhuket T; Wong RJ
    Hepatol Res; 2016 Jun; 46(7):669-77. PubMed ID: 26508039
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk factors for intrahepatic and extrahepatic cholangiocarcinoma: A systematic review and meta-analysis.
    Clements O; Eliahoo J; Kim JU; Taylor-Robinson SD; Khan SA
    J Hepatol; 2020 Jan; 72(1):95-103. PubMed ID: 31536748
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Trends in Incidence and Factors Affecting Survival of Patients With Cholangiocarcinoma in the United States.
    Mukkamalla SKR; Naseri HM; Kim BM; Katz SC; Armenio VA
    J Natl Compr Canc Netw; 2018 Apr; 16(4):370-376. PubMed ID: 29632056
    [No Abstract]   [Full Text] [Related]  

  • 16. Diabetes mellitus and increased risk of cholangiocarcinoma: a meta-analysis.
    Jing W; Jin G; Zhou X; Zhou Y; Zhang Y; Shao C; Liu R; Hu X
    Eur J Cancer Prev; 2012 Jan; 21(1):24-31. PubMed ID: 21857525
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatobiliary Cancer Risk in Patients with Inflammatory Bowel Disease: A Scandinavian Population-Based Cohort Study.
    Erichsen R; Olén O; Sachs MC; Pedersen L; Halfvarson J; Askling J; Ekbom A; Ludvigsson JF; Sørensen HT
    Cancer Epidemiol Biomarkers Prev; 2021 May; 30(5):886-894. PubMed ID: 33627380
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatitis B virus infection, diabetes mellitus, and their synergism for cholangiocarcinoma development: a case-control study in Korea.
    Lee BS; Park EC; Park SW; Nam CM; Roh J
    World J Gastroenterol; 2015 Jan; 21(2):502-10. PubMed ID: 25593465
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Non-alcoholic fatty liver disease as a risk factor for cholangiocarcinoma: a systematic review and meta-analysis.
    Wongjarupong N; Assavapongpaiboon B; Susantitaphong P; Cheungpasitporn W; Treeprasertsuk S; Rerknimitr R; Chaiteerakij R
    BMC Gastroenterol; 2017 Dec; 17(1):149. PubMed ID: 29216833
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increasing mortality in the United States from cholangiocarcinoma: an analysis of the National Center for Health Statistics Database.
    Yao KJ; Jabbour S; Parekh N; Lin Y; Moss RA
    BMC Gastroenterol; 2016 Sep; 16(1):117. PubMed ID: 27655244
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.